课题基金 / 基金详情

Investigation of a novel supramolecular organisation of the oligomeric mucins MUC5AC MUC5B and MUC2

Investigation of a novel supramolecular organisation of the oligomeric mucins MUC5AC MUC5B and MUC2
寡聚粘蛋白 MUC5AC MUC5B 和 MUC2 的新型超分子组织的研究
批准号:
BB/D522389/1
负责人:
David Thornton
金额:
$31.92万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --

项目摘要

项目成果

David Thornton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A layer of mucus is a common means of protecting the delicate exposed epithelial surfaces of an organism against its environment and a range of biological, chemical and physical insults. We have discovered that the gel-like characteristics of mucus in saliva and now potentially in other mucus gels (e.g. the respiratory, gastrointestinal and reproductive tracts) are caused by calcium binding in the large structural glycoproteins (mucins). Our evidence shows that this involves protein parts of the mucin linking mucin molecules together. Therefore we will identify the part(s) of the mucin responsible for calcium-binding by testing different parts of the molecule prepared separately and also in fragments of mucin purified from saliva. The details of how it functions and where it occurs in the structure of the mucin will be determined. We will also investigate whether mucins can be modified to remove or inactivate their calcium binding properties. This calcium dependent cross-link activity that we have detected in mucin is newly discovered and it is a potentially important mechanism contributing to the function of this vital protective barrier. Furthermore, an improved understanding of the organisation of this barrier has important implications for treatment of common diseases involving mucus overproduction (e.g. asthma and cystic fibrosis) and improved strategies for the delivery to and across epithelial surfaces of pharmaceuticals and gene therapy agents.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1074/jbc.m114.566679
发表时间: 2014-06-06
期刊: The Journal of biological chemistry
影响因子: --
作者: [Ridley C, Kouvatsos N, Raynal BD, Howard M, Collins RF, Desseyn JL, Jowitt TA, Baldock C, Davis CW, Hardingham TE, Thornton DJ]
通讯作者: Thornton DJ
Defining the mechanisms controlling mucus function
  • 批准号:
    BB/W006456/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $65.28万
  • 财政年份:
    2022
  • 负责人:
    David Thornton
  • 依托单位:
Sustainable Energy Engineering for Empowering Rural Communities
  • 批准号:
    1953601
  • 项目类别:
    Standard Grant
  • 资助金额:
    $13.03万
  • 财政年份:
    2020
  • 负责人:
    David Thornton
  • 依托单位:
A live model to study mucociliary clearance in health and disease
  • 批准号:
    NC/S001034/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $62.96万
  • 财政年份:
    2018
  • 负责人:
    David Thornton
  • 依托单位:
Unravelling the molecular mechanisms controlling respiratory tract mucus gel formation in health and disease
  • 批准号:
    MR/R002800/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.58万
  • 财政年份:
    2017
  • 负责人:
    David Thornton
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: